Marimastat - Moligand™, ≥99% , Matrix metalloproteinase 7 inhibitor, CAS No.154039-60-8, Matrix metalloproteinase 7 inhibitor

CAS: 154039-60-8 Cat. No.: M302985 Formule: C15H29N3O5 Poids moléculaire: 331.41
DISPONIBLE À COMMANDE
QUALITÉ & PURETÉ Moligand™ ? Moligand™ — Aladdin's line of ligands and bioactive small molecules. Use for receptor, pathway, and binding studies needing defined small-molecule tools. ≥99%
Synonyms
Butanediamide, N4-[(1S)-2,2-dimethyl-1-[(methylamino)carbonyl]propyl]-N1,2-dihydroxy-3-(2-methylpropyl)-, (2S,3R)-|GI 5712|(2S,3R)-3-[[(1S)-2,2-Dimethyl-1-(methylcarbamoyl)propyl]carbamoyl]-2-hydroxy-5-methylhexanohydroxamic acid|(2S,3R)-N'-[(1S)-2,2-dimethyl-1-(methylcarbamoyl)propyl]-N,2-dihydroxy-3-(2-methylpropyl)butanediamide|(2S,3R)-N-[(1S)-2,2-dimethyl-1-(methylcarbamoyl)propyl]-N',2-dihydroxy-3-(2-methylpropyl)butanediamide|Butaneamide,2-dimethyl-1-[(methylamino)carbonyl]propyl]- N1,2-dihydroxy-3-(2-methylpropyl)-, (2S,3R)-|Butanediamide, N4-((1S)-2,2-dimethyl-1-((methylamino)carbonyl)propyl)-N1,2-dihydroxy-3-(2-methylpropyl)-, (2S,3R)-|(2R,3S)-N1-((S)-3,3-dimethyl-1-(methylamino)-1-oxobutan-2-yl)-N4,3-dihydroxy-2-isobutylsuccinamide|(2S,3R)-3-(((1S)-2,2-Dimethyl-1-(methylcarbamoyl)propyl)carbamoyl)-2-hydroxy-5-methylhexanohydroxamic acid|BUTANEDIAMIDE, N(SUP 4)-(2,2-DIMETHYL-1-((METHYLAMINO)CARBONYL)PROPYL)-N1,2-DIHYDROXY-3-(2-METHYLPROPYL)-, (2S-(N4(R*),2R*,3S*))-|Marimastat|Marimastat - CAS 154039-60-8|1-(2-Nitrovinyl)-3,4-methylenedioxybenzene|MARIMASTAT [MART.]|MARIMASTAT [MI]|GI-5712|TA 2516|KB-R 8898|Marimastat (BB-2516)|Marimastat [USAN]|Marimastat [USAN:INN:BAN]|(2S,3R)-N(4)-[(2S)-3,3-dimethyl-1-(methylamino)-1-oxobutan-2-yl]-N(1),2-dihydroxy-3-(2-methylpropyl)butanediamide|(2R)-N-[(1S)-2,2-dimethyl-1-(methylcarbamoyl)propyl]-2-[(1S)-1-hydroxy-2-(hydroxyamino)-2-oxo-ethyl]-4-methyl-pentanamide|Butanediamide, N4-(2,2-dimethyl-1-((methylamino)carbonyl)propyl)-N1,2-dihydroxy-3-(2-methylpropyl)-, (2S-(N4(R*),2R*,3S*))-|Marimistat|BB 2516|TA-2516|Butanediamide, N(sup 4)-(2,2-dimethyl-1-((methylamino)carbonyl)propyl)-N(sup 1),2-dihydroxy-3-(2-methylpropyl)-, (2S-(N(sup 4)(R*),2R*,3S*))-|(2S,3R)-3-(((1S)-2,2-Dimethyl-1-(methylcarbamoxy)propyl)carboyl)-2-hydroxy-5-methylhexanohydroxamic acid|MARIMASTAT [INN]|BB2516|BB-2516|Marimastat (USAN/INN)
Storage
Store at -20°C
Shipped In
Ice chest + Ice pads
★
Taille
Allemagne (EU)
USA*
Prix
Qté
5mg
M302985-5mg
—
6 En stock

39,83€

59,79€
Enregistrer 19,96 € (33.38%)
10mg
M302985-10mg
—
3 En stock

71,94€

108,38€
Enregistrer 36,45 € (33.63%)
25mg
M302985-25mg
—
2 En stock

156,11€

234,20€
Enregistrer 78,10 € (33.35%)
50mg
M302985-50mg
—
2 En stock

233,34€

350,48€
Enregistrer 117,14 € (33.42%)
100mg
M302985-100mg
—
2 En stock

351,35€

527,50€
Enregistrer 176,15 € (33.39%)
200mg
M302985-200mg
—
2 En stock

632,49€

949,22€
Enregistrer 316,72 € (33.37%)
Enter a quantity for the sizes you want to add.

Spécifications

Synonymes
Butanediamide, N4-[(1S)-2,2-dimethyl-1-[(methylamino)carbonyl]propyl]-N1,2-dihydroxy-3-(2-methylpropyl)-, (2S,3R)- | GI 5712 | (2S,3R)-3-[[(1S)-2,2-Dimethyl-1-(methylcarbamoyl)propyl]carbamoyl]-2-hydroxy-5-methylhexanohydroxamic acid | (2S,3R)-N'-[(1S)-2,2-dimethyl-1-(methylcarbamoyl)propyl]-N,2-dihydroxy-3-(2-methylpropyl)butanediamide | Afficher plus
Spécifications et pureté
Moligand™, ≥99%
Mécanismes biochimiques et physiologiques
Potent matrix metalloproteinase inhibitor. Broad-spectrum inhibitor of all major MMPs. Prevents or reduces spread and growth of tumors.
Conditions de stockage de stockage
Store at -20°C
Expédié en
Ice chest + Ice pads
Ce produit nécessite l'expédition en chaîne froide. Les services terrestres et autres services économiques ne sont pas disponibles.
Grade
Moligand™
Type d'action
INHIBITOR
Mécanisme d'action
Matrix metalloproteinase 7 inhibitor
Note
Wherever possible, you should prepare and use solutions on the same day. However, if you need to make up stock solutions in advance, we recommend that you store the solution as aliquots in tightly sealed vials at -20°C. Generally, these will be useable for up to one month. Before use, and prior to opening the vial we recommend that you allow your product to equilibrate to room temperature for at least 1 hour. Need more advice on solubility, usage and handling? Please visit our frequently asked questions (FAQ) page for more details.
Pureté
≥99%
Propriétés du produit
ALogP
0.5
Noms et identifiants
Pubchem Sid
Pubchem Sid Url
https://pubchem.ncbi.nlm.nih.gov/substance/488187602
SMILES
CC(C)CC(C(C(=O)NO)O)C(=O)NC(C(=O)NC)C(C)(C)C
IUPAC Name
(2R,3S)-N-[(2S)-3,3-dimethyl-1-(methylamino)-1-oxobutan-2-yl]-N',3-dihydroxy-2-(2-methylpropyl)butanediamide
InChIKey
OCSMOTCMPXTDND-OUAUKWLOSA-N
InChI
1S/C15H29N3O5/c1-8(2)7-9(10(19)13(21)18-23)12(20)17-11(14(22)16-6)15(3,4)5/h8-11,19,23H,7H2,1-6H3,(H,16,22)(H,17,20)(H,18,21)/t9-,10+,11-/m1/s1
Isomères SMILES
CC(C)C[C@H]([C@@H](C(=O)NO)O)C(=O)N[C@H](C(=O)NC)C(C)(C)C
Poids moléculaire
331.41
Reaxys
24715440
Reaxys-RN_link_address
https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN=24715440&ln=

Données avancées

Taxonomic Classification

Taxonomy Tree

KingdomOrganic compounds
SuperclassOrganic oxygen compounds
ClasseOrganooxygen compounds
SubclassAlcohols and polyols
Intermediate Tree Nodes Not available
Direct ParentSecondary alcohols
Alternative Parents Propargyl-type 1,3-dipolar organic compounds  Carboximidic acids  Organopnictogen compounds  Organonitrogen compounds  Hydrocarbon derivatives  
Molecular FrameworkAliphatic acyclic compounds
Substituents Secondary alcohol - Organic 1,3-dipolar compound - Propargyl-type 1,3-dipolar organic compound - Carboximidic acid derivative - Carboximidic acid - Organic nitrogen compound - Organopnictogen compound - Hydrocarbon derivative - Organonitrogen compound - Aliphatic acyclic compound
DescriptionThis compound belongs to the class of organic compounds known as secondary alcohols. These are compounds containing a secondary alcohol functional group, with the general structure HOC(R)(R') (R,R'=alkyl, aryl).
External Descriptors tricarboxylic acid triamide
Structure 3D
Modèle de structure chimique interactif





Cibles associées (humaines)
TNF Tclin Tumor necrosis factor (1 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
MMP1 Tchem Interstitial collagenase (14 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
MMP7 Tchem Matrilysin (3 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
MMP13 Tchem Collagenase 3 (7 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
MMP14 Tchem Matrix metalloproteinase-14 (1 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
MMP9 Tchem Matrix metalloproteinase-9 (9 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
MMP2 Tchem 72 kDa type IV collagenase (13 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
ADAM17 Tchem Disintegrin and metalloproteinase domain-containing protein 17 (7 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
MMP3 Tchem Stromelysin-1 (12 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
MMP8 Tchem Neutrophil collagenase (3 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
TNF Tclin TNF-alpha (1897 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MMP26 Tchem Matrix metalloproteinase 26 (24 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MMP15 Tchem Matrix metalloproteinase 15 (49 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MMP16 Tchem Matrix metalloproteinase 16 (81 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MMP3 Tchem Matrix metalloproteinase 3 (3433 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MMP8 Tchem Matrix metalloproteinase 8 (1942 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MMP14 Tchem Matrix metalloproteinase 14 (1592 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MMP12 Tchem Matrix metalloproteinase 12 (1130 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MMP10 Tchem Matrix metalloproteinase 10 (359 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MMP7 Tchem Matrix metalloproteinase 7 (1073 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADAMTS4 Tchem ADAMTS4 (425 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADAMTS5 Tchem ADAMTS5 (711 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MMP1 Tchem Matrix metalloproteinase-1 (7046 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
THP-1 (11052 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADAM10 Tchem ADAM10 (375 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MMP24 Tbio Matrix metalloproteinase-24 (6 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MMP25 Tchem Matrix metalloproteinase-25 (11 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MMP20 Tbio Matrix metalloproteinase-20 (10 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MMP13 Tchem Matrix metalloproteinase (1 and 13) (154 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Cibles associées (non humaines)
Mmp13 Matrix metalloproteinase 13 (19 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Adam17 ADAM17 (14 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Mmp2 Matrix metalloproteinase-2 (12 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Hdac6 Histone deacetylase 6 (222 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Mmp9 Matrix metalloproteinase 9 (38 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Mus musculus (284745 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Rattus norvegicus (775804 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
rep Replicase polyprotein 1ab (378 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
dpy-31 Metalloendopeptidase (5 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Mécanismes d'action
Certificats (CoA, COO, BSE/TSE et tableau d'analyse)
C of A & Other Certificates(BSE/TSE, COO):
Analytical Chart:

Find and download the COA for your product by matching the lot number on the packaging.

13 results found

Lot NumberCertificate TypeDateArticle
D23181263D23181263Certificate of AnalysisMar 13, 2023 M302985
D23181299D23181299Certificate of AnalysisMar 13, 2023 M302985
D23181359D23181359Certificate of AnalysisMar 13, 2023 M302985
D23181363D23181363Certificate of AnalysisMar 13, 2023 M302985
D23181364D23181364Certificate of AnalysisMar 13, 2023 M302985
D23181365D23181365Certificate of AnalysisMar 13, 2023 M302985
D23181368D23181368Certificate of AnalysisMar 13, 2023 M302985
D23181369D23181369Certificate of AnalysisMar 13, 2023 M302985
D23181397D23181397Certificate of AnalysisMar 13, 2023 M302985
D23181401D23181401Certificate of AnalysisMar 13, 2023 M302985
D23181420D23181420Certificate of AnalysisMar 13, 2023 M302985
D23181421D23181421Certificate of AnalysisMar 13, 2023 M302985
K2511062K2511062Certificate of AnalysisMar 13, 2023 M302985
Propriétés chimiques et physiques
SolubilitéDMSO: ≥20 mg/mL
Point de fusion (°C)148°C
Poids moléculaire331.41
XLogP30.500
Hydrogen Bond Donor Count5
Hydrogen Bond Acceptor Count5
Rotatable Bond Count8
Exact Mass331.211 Da
Monoisotopic Mass331.211 Da
Topological Polar Surface Area128.000 Ų
Heavy Atom Count23
Formal Charge0
Complexity431.000
Isotope Atom Count0
Defined Atom Stereocenter Count3
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
The total count of all stereochemical bonds0
Covalently-Bonded Unit Count1
Sécurité et dangers (GHS)
Conseils de prudence

P264:Wash hands [and …] thoroughly after handling.

Reaxys
24715440
Reaxys-RN_link_address
https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN=24715440&ln=
FAQ et articles
Calculateurs de solution
Avis

Avis des clients

Besoin d'aide pour choisir la qualité ?

Notre guide de sélection des qualités couvre la pureté, le statut du stabilisant et l'adéquation à l'application pour toutes les variantes de notre catalogue.

Voir le guide des qualités Moligand™ →

Produits apparentés

Orlistat - Moligand™, ≥97%, used for Orlistat has been used as an inhibitor: of fatty acid synthase in long-term estrogen-deprived (LTED) variant cell lines of lipase in screening lipase inhibition by raspberry extract in in vitro pancreatic lipase activi
Oseltamivir phosphate - Moligand™,≥99% , Neuraminidase inhibitor, CAS No.204255-11-8
Ulinastatin - 2000 units/mg , CAS No.80449-31-6
Ulipristal acetate - Moligand™, ≥98%(HPLC) , Progesterone receptor modulator, CAS No.126784-99-4
Oseltamivir - Moligand™, ≥98% , CAS No.196618-13-0
Panobinostat (LBH589) - Moligand™, ≥98% , Inhibitor of histone deacetylase 1;Inhibitor of histone deacetylase 2;Inhibitor of histone deacetylase 3;Inhibitor of histone deacetylase 4;Inhibitor of histone deacetylase 6;Inhibitor of histone deacetylase 7;Inh
Pentostatin - Moligand™, ≥98%(HPLC) , Adenosine deaminase inhibitor, CAS No.53910-25-1
LAQ824 - Moligand™, ≥98% , Inhibitor of histone deacetylase 1;Inhibitor of histone deacetylase 2;Inhibitor of histone deacetylase 3;Inhibitor of histone deacetylase 4;Inhibitor of histone deacetylase 5;Inhibitor of histone deacetylase 6;Inhibitor of histo
DOLASTATIN 10 - ≥98% , Tubulin inhibitor, CAS No.110417-88-4
Alrestatin - ≥98% , CAS No.51411-04-2
Alvelestat - Moligand™, ≥98% , Leukocyte elastase inhibitor, CAS No.848141-11-7
Belinostat (PXD101) - Moligand™, ≥98% , Inhibitor of histone deacetylase 1;Inhibitor of histone deacetylase 2;Inhibitor of histone deacetylase 3;Inhibitor of histone deacetylase 4;Inhibitor of histone deacetylase 5;Inhibitor of histone deacetylase 6;Inhib
Batimastat - Moligand™, ≥98% , Inhibitor of MMP1;Inhibitor of MMP13;Inhibitor of MMP3, CAS No.130370-60-4
E-64c - ≥98% , CAS No.76684-89-4
Epalrestat - Moligand™, ≥97% , Aldose reductase inhibitor, CAS No.82159-09-9
Istaroxime , Sarcoplasmic/endoplasmic reticulum calcium ATPase 2 activator, CAS No.203737-93-3
Topiroxostat - Moligand™, ≥98% , Xanthine dehydrogenase inhibitor, CAS No.577778-58-6
Tolrestat(AY-27773) - Moligand™, ≥98% , Aldose reductase inhibitor, CAS No.82964-04-3
Verubecestat (MK-8931) - Moligand™, ≥98% , Beta-secretase 1 inhibitor, CAS No.1286770-55-5
Nafamostat Mesylate - Moligand™, ≥98% , CAS No.82956-11-4
Oseltamivir-d3 Acid - ≥98 atom% D,≥98% , CAS No.1242184-43-5
Belinostat - ≥98%(HPLC) , Histone deacetylase inhibitor, CAS No.866323-14-0
Nepicastat (SYN-117) HCl - ≥98% , CAS No.170151-24-3
Stiripentol-d9 , CAS No.1185239-64-8
Vadadustat - Moligand™, ≥97% , Hypoxia-inducible factor prolyl hydroxylase 1 inhibitor, CAS No.1000025-07-9
CUDC-907 - Moligand™, ≥98% , Histone deacetylase inhibitor, CAS No.1339928-25-4
Cetilistat - Moligand™, 2mM in DMSO , Gastric lipase inhibitor, CAS No.282526-98-1
Cetilistat - Moligand™, ≥98%(HPLC) , Gastric lipase inhibitor, CAS No.282526-98-1
Cilastatin - Moligand™, ≥98% , Renal dipeptidase inhibitor, CAS No.82009-34-5
Cilastatin Sodium - ≥98% , Renal dipeptidase inhibitor, CAS No.81129-83-1
Citarinostat (ACY-241) - Moligand™, ≥98% , Inhibitor of histone deacetylase 1;Inhibitor of histone deacetylase 2;Inhibitor of histone deacetylase 3;Inhibitor of histone deacetylase 6;Inhibitor of histone deacetylase 8, CAS No.1316215-12-9
Citarinostat (ACY-241) - Moligand™, 10mM in DMSO , Inhibitor of histone deacetylase 1;Inhibitor of histone deacetylase 2;Inhibitor of histone deacetylase 3;Inhibitor of histone deacetylase 6;Inhibitor of histone deacetylase 8, CAS No.1316215-12-9
Cobicistat (GS-9350) - Moligand™, ≥98% , Cytochrome P450 3A inhibitor, CAS No.1004316-88-4
Dolastatin 15 - ≥98% , CAS No.123884-00-4
E-64c - 10mM in DMSO , CAS No.76684-89-4
Eliglustat hemitartrate - ≥99% , CAS No.928659-70-5
Eliglustat hemitartrate - 10mM in DMSO , CAS No.928659-70-5
Epalrestat - Moligand™, 2mM in DMSO , Aldose reductase inhibitor, CAS No.82159-09-9
Fimepinostat (CUDC-907) - Moligand™, 10mM in DMSO , Histone deacetylase inhibitor, CAS No.1339928-25-4
Filastatin - ≥98% , CAS No.431996-53-1
Liproxstatin-1 - Moligand™, ≥97% , CAS No.950455-15-9
Nafamostat mesilate (FUT-175) - 10mM in DMSO , CAS No.82956-11-4
Oseltamivir phosphate - Moligand™,2mM in DMSO , Neuraminidase inhibitor, CAS No.204255-11-8
Orlistat (Ro 18-0647) - Moligand™, 10mM in DMSO , Pancreatic lipase inhibitor, CAS No.96829-58-2
Panobinostat (LBH589) - Moligand™, 10mM in DMSO , Inhibitor of histone deacetylase 1;Inhibitor of histone deacetylase 2;Inhibitor of histone deacetylase 3;Inhibitor of histone deacetylase 4;Inhibitor of histone deacetylase 6;Inhibitor of histone deacetyla
Pentostatin - Moligand™, 10mM in DMSO , Adenosine deaminase inhibitor, CAS No.53910-25-1
Quisinostat (JNJ-26481585) 2HCl - ≥98% , CAS No.875320-31-3
Quisinostat (JNJ-26481585) 2HCl - 10mM in DMSO , CAS No.875320-31-3
Seclidemstat - ≥98% , CAS No.1423715-37-0
Spastazoline - Moligand™, ≥98% , CAS No.2351882-11-4
Tinostamustine(EDO-S101) - 10mM in DMSO , CAS No.1236199-60-2
Ulipristal Acetate (CDB 2914) - Moligand™, 10mM in DMSO , Progesterone receptor modulator, CAS No.126784-99-4

Souhaitez-vous que nous vous envoyions un message lorsque des réductions seront disponibles?

Me rappeler plus tard

Merci ! Veuillez vérifier votre boîte de réception e-mail pour confirmer.

Oups ! Les notifications sont désactivées.